High-intensity focused ultrasound ablation: An effective bridging therapy for hepatocellular carcinoma patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

367

HTML

3430

Figures (1-2)

215

Tables (1-2)

217

Sum=4229

Publishing Process of This Article

Item

Count

Browse

1133

Download

287

Sum=1420

May 28, 2013 (publication date) through Jul 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 28, 2013; 19(20): 3083-3089
Published online May 28, 2013. doi: 10.3748/wjg.v19.i20.3083

Table 1 Patient demographics

	HIFU (n = 10)	TACE (n = 29)	P value
Age (yr)	59.5 (49-76)	57 (43-65)	0.107
Sex (male/female)	7/3	24/5	0.399
Child-Pugh A disease	3 (30)	17 (58.6)	0.267
Child-Pugh B disease	6 (60)	12 (41.4)
Child-Pugh C disease	1 (10)	0
Carrier of hepatitis B virus	5 (50)	28 (96.5)	0.002
Carrier of hepatitis C virus	4 (40)	1 (3.4)	0.011
Serum bilirubin (μmol/L)	14.5 (6-36)	25 (4-49)	0.074
Serum albumin (g/dL)	32 (27-38)	34 (20-43)	0.606
Platelet count (10⁹/L)	67 (28-166)	59 (23-144)	0.688
Aspartate transaminase (U/L)	52 (29-141)	47 (15-104)	0.440
Alanine transaminase (U/L)	44 (26-109)	36 (9-132)	0.376
Alpha-fetoprotein (ng/mL)	8 (2-160)	24 (1-1151)	0.101
International normalized ratio	1.25 (0.9-1.5)	1.3 (1.0-1.5)	0.960
Largest tumor size (cm)	2.6 (1.2-4.0)	2.0 (0.8-4.3)	0.252
Tumor number	1 (1-2)	1 (1-3)	0.172

Data are expressed as absolute n (%) or median (range). HIFU: High-intensity focused ultrasound; TACE: Transarterial chemoembolization.

Citation: Cheung TT, Fan ST, Chan SC, Chok KS, Chu FS, Jenkins CR, Lo RC, Fung JY, Chan AC, Sharr WW, Tsang SH, Dai WC, Poon RT, Lo CM. High-intensity focused ultrasound ablation: An effective bridging therapy for hepatocellular carcinoma patients. World J Gastroenterol 2013; 19(20): 3083-3089
URL: https://www.wjgnet.com/1007-9327/full/v19/i20/3083.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i20.3083